Embracing Diversity & Inclusion
Clinical Trial Diversity, Flexibility Championed By The Food And Drug Omnibus Reform Act
The Food and Drug Omnibus Reform Act, signed into law by President Biden on Dec. 29, 2022, includes provisions intended to modernize clinical trials and are broadly divided into two categories: encouraging the enrollment of diverse populations and facilitating novel clinical trial designs.
AI And Healthcare Disparities: Driving A Wedge Or Closing The Gap?
The enthusiasm for the role of AI in upgrading global health and care provision is justified, provided we understand that the path to success is just as much about communication and collaborative development as it is about the raw potential of the technology itself. Because realizing this technological potential requires us to consider the role of people and processes in an integrated approach.
Start Early, Collaborate Often: Key Steps To More Diverse Clinical Trials
Overcoming the diversity gap in clinical trial research requires multilevel approaches and collaborative partnerships. Genentech's Alekhya Pochiraju reveals four easy ways sponsors can together with their site sites foster more patient diversity and shows us the importance of prioritizing diversity at the program and portfolio level.
How Africa Can Help Reverse Underrepresentation In Clinical Trials
In the U.S., 13% of the population is Black, yet only 5% are represented in clinical trials. Historical knowledge tells us a similar disparity exists globally for African representation in clinical trials. Tina Barton, COO of eMQT Ltd., declares now as the time to overcome fears and hesitations to bring more clinical trials to Sub-Saharan Africa.
Underrepresentation & Overconsumption: Exploring The Gap In Global Clinical Trial Diversity
It is well known that certain ethnic groups are routinely underrepresented in global clinical trials. But another data set now shows that some of those ethnic groups are also disproportionately consuming pharmaceuticals. Vladimir Misik, of VIARES Academy, explores why that is — and how to rectify it.
Expanding Eligibility — And 6 More Tips For Improving Trial Diversity
It is no secret that people who are ethnically diverse are underrepresented in clinical trials, and that is a trend that needs to change. But how? Discover six ways you can increase trial diversity starting now.
Raising Minority Enrollment With Creativity And Collaboration
With all the focus on patient diversity, are we actually seeing more diverse clinical trials? The answer might surprise you. Hear from Van R. Johnson as he shares meaningful and personal insights to help increase minority enrollment in clinical trials.
Breaking The Socioeconomic Barriers To Clinical Trial Participation
The data is there: Patients with a low socioeconomic status (SES) have at a disadvantage when it comes to healthcare. And that's still true when it comes to clinical trial participation. Understanding those barriers and how to break through them is essential to improving enrollment for underserved populations.
Two Straightforward Ways To Improve DE&I In Clinical Trials
We don’t have to wait for federal guidance, additional DHT, or new innovations. We have the tools to begin to address the lack of trust and limited data and incorporate them into diversity plans for clinical trials today. Here's how.
Gaining Trust, Giving Support, & Forgetting The “Perfect Patient”: Ways To Achieve Diverse Clinical Trial Recruitment
Forget the "perfect patient" and find the right patient. Pandy Opima, M.D., director study leader, Early Oncology R&D, at AstraZeneca, presents ways to truly achieve clinical trial diversity.